'Multimorbidity': an acceptable term for patients or time for a rebrand?

Affiliations

¹ Research Institute, Primary Care & Health Sciences, Keele University, Keele.
² CEO of Versus Arthritis and Chairman of the Taskforce on Multiple Long-Term Conditions, London.
³ Taskforce on Multiple Long-Term Conditions; Chair of the Patient Insight Group at Versus Arthritis and a member of NIHR INVOLVE advisory group, London.
⁴ Centre for Academic Primary Care, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol.

Editorial

Carolyn Chew-Graham et al. Br J Gen Pract. 2019 Aug.

. 2019 Aug;69(685):372-373.

doi: 10.3399/bjgp19X704681.

¹ Research Institute, Primary Care & Health Sciences, Keele University, Keele.
² CEO of Versus Arthritis and Chairman of the Taskforce on Multiple Long-Term Conditions, London.
³ Taskforce on Multiple Long-Term Conditions; Chair of the Patient Insight Group at Versus Arthritis and a member of NIHR INVOLVE advisory group, London.
⁴ Centre for Academic Primary Care, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol.

No abstract available

Figures

1. Starfield B. Threads and yarns: weaving the tapestry of comorbidity. Ann Fam Med. 2006;4(2):101–103. - PMC - PubMed
1. Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis. 1970;23(7):455–468. - PubMed
1. Valderas JM, Starfield B, Sibbald B, et al. Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009;7(4):357–363. - PMC - PubMed
1. Fortin M, Stewart M, Poitras ME, et al. A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Ann Fam Med. 2012;10(2):142–151. - PMC - PubMed
1. Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37–43. - PubMed